secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telomir Pharmaceuticals, Inc. (TELO)
CIK:        0001971532
Form:       8-K
Filed at:   2024-12-11T23:59:59+00:00
Accession:  0001493152-24-049630
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 3.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Telomir Pharmaceuticals raises $1M at $7/share (20% premium) in no-warrant private placement
--------------------------------------------------------------------------------

- Issued 142,857 shares at $7/share to an accredited investor, a 20% premium to Dec 9 closing price.
- Total proceeds $1M; no warrants issued, minimizing dilution.
- Same investor extended a $5M non-dilutive line of credit earlier in 2024, currently undrawn.
- Exempt from registration under Section 4(a)(2) of the Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971532/000149315224049630/0001493152-24-049630-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971532/000149315224049630/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-049630

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer